3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid has been researched along with captopril in 4 studies
| Studies (3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid) | Trials (3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid) | Recent Studies (post-2010) (3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 10,320 | 1,514 | 890 |
| Protein | Taxonomy | 3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid (IC50) | captopril (IC50) |
|---|---|---|---|
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
| Beta-lactamase | Pseudomonas aeruginosa | 5 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dugan, DH; Essenburg, AD; Hoefle, ML; Kaplan, HR; Klutchko, S; Nemeth, VL; Parker, RB; Ryan, MJ; Smith, RD | 1 |
| Condon, ME; Cushman, DW; Heikes, JE; Losee, KA; Neubeck, R; Ondetti, MA; Petrillo, EW; Puar, M; Reid, JA; Ryono, DE; Sabo, EF | 1 |
| Desai, M; Gavin, T; Watthey, JW | 1 |
| Holmquist, B; Neels, H; Scharpé, S; van Sande, M | 1 |
4 other study(ies) available for 3-(mercaptomethyl)-2-oxo-1-piperidineacetic acid and captopril
| Article | Year |
|---|---|
Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chemical Phenomena; Chemistry; Dogs; Guinea Pigs; Hemodynamics; In Vitro Techniques; Muscle Contraction; Pyrrolidinones; Pyrrolidonecarboxylic Acid | 1981 |
Angiotensin-converting enzyme inhibitors: importance of the amide carbonyl of mercaptoacyl amino acids for hydrogen bonding to the enzyme.
Topics: Amino Acids, Sulfur; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry, Physical; Hydrogen Bonding; In Vitro Techniques; Lung; Molecular Conformation; Rabbits; Structure-Activity Relationship | 1982 |
Bicyclic lactam inhibitors of angiotensin converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azocines; Benzazepines; Captopril; Lung; Male; Proline; Rabbits | 1984 |
Kininase II of human seminal fluid: kinetics and inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding, Competitive; Captopril; Chlorides; Enalapril; Humans; Kinetics; Male; Peptidyl-Dipeptidase A; Piperidines; Piperidones; Semen; Spermatozoa | 1986 |